We are focused on finding Therapeutics for ftd caused by mutations in the progranulin gene.
Bluefield by the Numbers
2
drugs in clinical trials
100
peer reviewed publications
26
investigators funded
50
Trainees
Support the Bluefield Project
We’re committed to advancing our understanding of frontotemporal dementia to find a treatment or cure. And we’re making great progress. You can help too.